TERRENCE G LINNERT Insider Trading $GR GOODRICH CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for TERRENCE G LINNERT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of TERRENCE G LINNERT. TERRENCE G LINNERT is Executive Vice President in GOODRICH CORP ($GR) and Executive VP & General Counsel in GOODRICH CORP ($GR).
TERRENCE G LINNERT in GOODRICH CORP
Trading Symbol: GRIndustry: GUIDED MISSILES & SPACE VEHICLES & PARTS [3760]
Position of TERRENCE G LINNERT: Executive VP & General Counsel, Executive Vice President
Holdings: 0 shares
Latest Transaction: Jul 30 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of TERRENCE G LINNERT in GOODRICH CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 30 2012 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | D | 32.43 | 25,000 | 810,750 | 0 | |
Jul 30 2012 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | D | 40.41 | 23,000 | 929,315 | 0 | |
Jul 30 2012 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | D | 45.87 | 50,000 | 2,293,500 | 0 | |
Jul 30 2012 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | D | 45.87 | 16,500 | 756,855 | 0 | |
Jul 30 2012 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | D | 69.87 | 26,500 | 1,851,423 | 0 | |
Jul 30 2012 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | D | 38.37 | 27,000 | 1,035,990 | 0 | |
Jul 30 2012 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | D | 65.32 | 22,000 | 1,436,930 | 0 | |
Jul 30 2012 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | D | 88.64 | 22,000 | 1,949,970 | 0 | |
Jul 30 2012 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | D | 0.00 | 617 | 0 | 0 | |
Jul 30 2012 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | D | 127.50 | 1,060 | 135,150 | 0 | 1.1 K to 0 (-100.00 %) |
Jul 30 2012 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | D | 127.50 | 31,666 | 4,037,415 | 0 | 31.7 K to 0 (-100.00 %) |
Jul 30 2012 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | D | 127.50 | 29,500 | 3,761,250 | 31,666 | 61.2 K to 31.7 K (-48.23 %) |
Jul 30 2012 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Gift | G | 0.00 | 1,200 | 0 | 61,166 | 62.4 K to 61.2 K (-1.92 %) |
Jan 05 2012 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Payment of Exercise | F | 123.60 | 2,648 | 327,293 | 62,366 | 65 K to 62.4 K (-4.07 %) |
May 13 2011 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 89.86 | 4,500 | 404,388 | 65,014 | 69.5 K to 65 K (-6.47 %) |
Feb 07 2011 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 93.56 | 5,000 | 467,800 | 69,514 | 74.5 K to 69.5 K (-6.71 %) |
Jan 05 2011 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | A | 88.64 | 22,000 | 1,949,970 | 22,000 | |
Jan 05 2011 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Payment of Exercise | F | 88.64 | 2,756 | 244,292 | 74,514 | 77.3 K to 74.5 K (-3.57 %) |
Jan 05 2011 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Grant | A | 0.00 | 9,000 | 0 | 77,270 | 68.3 K to 77.3 K (+13.18 %) |
Dec 20 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 86.49 | 3,000 | 259,470 | 68,270 | 71.3 K to 68.3 K (-4.21 %) |
Nov 03 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 83.31 | 5,114 | 426,041 | 71,270 | 76.4 K to 71.3 K (-6.70 %) |
Aug 09 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | M | 30.53 | 27,750 | 847,208 | 0 | |
Aug 09 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | M | 25.10 | 10,000 | 251,010 | 0 | |
Aug 09 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 74.80 | 27,750 | 2,075,686 | 76,384 | 104.1 K to 76.4 K (-26.65 %) |
Aug 09 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 74.77 | 10,000 | 747,735 | 104,134 | 114.1 K to 104.1 K (-8.76 %) |
Aug 09 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Buy | M | 30.53 | 27,750 | 847,208 | 114,134 | 86.4 K to 114.1 K (+32.12 %) |
Aug 09 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Buy | M | 25.10 | 10,000 | 251,010 | 86,384 | 76.4 K to 86.4 K (+13.09 %) |
Apr 27 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | M | 18.76 | 5,330 | 99,991 | 0 | |
Apr 27 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 76.00 | 5,330 | 405,080 | 76,384 | 81.7 K to 76.4 K (-6.52 %) |
Apr 27 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Buy | M | 18.76 | 5,330 | 99,991 | 81,714 | 76.4 K to 81.7 K (+6.98 %) |
Mar 10 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | M | 25.10 | 10,000 | 251,010 | 10,000 | |
Mar 10 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.71 | 10,000 | 697,063 | 76,384 | 86.4 K to 76.4 K (-11.58 %) |
Mar 10 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Buy | M | 25.10 | 10,000 | 251,010 | 86,384 | 76.4 K to 86.4 K (+13.09 %) |
Mar 03 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | M | 25.10 | 12,535 | 314,641 | 20,000 | |
Mar 03 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 67.17 | 12,535 | 841,976 | 76,384 | 88.9 K to 76.4 K (-14.10 %) |
Mar 03 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Buy | M | 25.10 | 12,535 | 314,641 | 88,919 | 76.4 K to 88.9 K (+16.41 %) |
Jan 06 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | A | 65.32 | 22,000 | 1,436,930 | 22,000 | |
Jan 06 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Payment of Exercise | F | 65.31 | 2,958 | 193,187 | 76,384 | 79.3 K to 76.4 K (-3.73 %) |
Jan 06 2010 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Grant | A | 0.00 | 9,000 | 0 | 79,342 | 70.3 K to 79.3 K (+12.79 %) |
Dec 16 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | I | 62.77 | 5,615 | 352,454 | 0 | 5.6 K to 0 (-100.00 %) |
Nov 20 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | M | 25.10 | 3,984 | 100,002 | 0 | |
Nov 20 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | M | 34.20 | 2,924 | 100,011 | 0 | |
Nov 20 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 60.49 | 3,984 | 241,007 | 70,342 | 74.3 K to 70.3 K (-5.36 %) |
Nov 20 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 60.49 | 2,924 | 176,886 | 74,326 | 77.3 K to 74.3 K (-3.79 %) |
Nov 20 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Buy | M | 25.10 | 3,984 | 100,002 | 77,250 | 73.3 K to 77.3 K (+5.44 %) |
Nov 20 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Buy | M | 34.20 | 2,924 | 100,011 | 73,266 | 70.3 K to 73.3 K (+4.16 %) |
Aug 31 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Gift | G | 0.00 | 720 | 0 | 70,342 | 71.1 K to 70.3 K (-1.01 %) |
Aug 25 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | M | 18.76 | 20,000 | 375,200 | 0 | |
Aug 25 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 57.37 | 20,000 | 1,147,400 | 71,062 | 91.1 K to 71.1 K (-21.96 %) |
Aug 25 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Buy | M | 18.76 | 20,000 | 375,200 | 91,062 | 71.1 K to 91.1 K (+28.14 %) |
Jun 15 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Gift | G | 0.00 | 200 | 0 | 71,062 | 71.3 K to 71.1 K (-0.28 %) |
Jun 15 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Gift | G | 0.00 | 200 | 0 | 71,262 | 71.5 K to 71.3 K (-0.28 %) |
Jun 15 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Gift | G | 0.00 | 400 | 0 | 71,462 | 71.9 K to 71.5 K (-0.56 %) |
Apr 27 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | M | 25.49 | 2,000 | 50,976 | 0 | |
Apr 27 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 45.99 | 2,000 | 91,982 | 71,862 | 73.9 K to 71.9 K (-2.71 %) |
Apr 27 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Buy | M | 25.49 | 2,000 | 50,976 | 73,862 | 71.9 K to 73.9 K (+2.78 %) |
Feb 18 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Payment of Exercise | F | 38.49 | 1,003 | 38,605 | 71,862 | 72.9 K to 71.9 K (-1.38 %) |
Feb 18 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Grant | A | 0.00 | 5,000 | 0 | 72,865 | 67.9 K to 72.9 K (+7.37 %) |
Feb 09 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | M | 25.49 | 1,923 | 49,013 | 2,000 | |
Feb 09 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 40.58 | 1,923 | 78,037 | 67,865 | 69.8 K to 67.9 K (-2.76 %) |
Feb 09 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Buy | M | 25.49 | 1,923 | 49,013 | 69,788 | 67.9 K to 69.8 K (+2.83 %) |
Jan 06 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | A | 38.37 | 27,000 | 1,035,990 | 27,000 | |
Jan 06 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Payment of Exercise | F | 39.40 | 2,636 | 103,858 | 67,865 | 70.5 K to 67.9 K (-3.74 %) |
Jan 06 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Grant | A | 0.00 | 8,750 | 0 | 70,501 | 61.8 K to 70.5 K (+14.17 %) |
Jan 02 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | M | 34.65 | 2,885 | 99,971 | 0 | |
Jan 02 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 36.21 | 300 | 10,863 | 61,751 | 62.1 K to 61.8 K (-0.48 %) |
Jan 02 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 36.20 | 2,585 | 93,577 | 62,051 | 64.6 K to 62.1 K (-4.00 %) |
Jan 02 2009 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Buy | M | 34.65 | 2,885 | 99,971 | 64,636 | 61.8 K to 64.6 K (+4.67 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | M | 34.20 | 4,380 | 149,812 | 0 | |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | M | 25.49 | 36,664 | 934,492 | 0 | |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 68.06 | 100 | 6,806 | 61,751 | 61.9 K to 61.8 K (-0.16 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 68.06 | 800 | 54,444 | 61,851 | 62.7 K to 61.9 K (-1.28 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 68.05 | 1,600 | 108,880 | 62,651 | 64.3 K to 62.7 K (-2.49 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 68.05 | 600 | 40,827 | 64,251 | 64.9 K to 64.3 K (-0.93 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 68.04 | 1,600 | 108,864 | 64,851 | 66.5 K to 64.9 K (-2.41 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 68.02 | 100 | 6,802 | 66,451 | 66.6 K to 66.5 K (-0.15 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 68.01 | 700 | 47,607 | 66,551 | 67.3 K to 66.6 K (-1.04 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 68.01 | 300 | 20,402 | 67,251 | 67.6 K to 67.3 K (-0.44 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 68.01 | 100 | 6,801 | 67,551 | 67.7 K to 67.6 K (-0.15 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 68.00 | 14,500 | 986,000 | 67,651 | 82.2 K to 67.7 K (-17.65 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 67.93 | 200 | 13,586 | 82,151 | 82.4 K to 82.2 K (-0.24 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 67.89 | 300 | 20,367 | 82,351 | 82.7 K to 82.4 K (-0.36 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 67.88 | 2,980 | 202,282 | 82,651 | 85.6 K to 82.7 K (-3.48 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 67.87 | 900 | 61,083 | 85,631 | 86.5 K to 85.6 K (-1.04 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 67.86 | 4,100 | 278,226 | 86,531 | 90.6 K to 86.5 K (-4.52 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 67.85 | 3,164 | 214,677 | 90,631 | 93.8 K to 90.6 K (-3.37 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 67.84 | 1,500 | 101,760 | 93,795 | 95.3 K to 93.8 K (-1.57 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 67.83 | 1,200 | 81,396 | 95,295 | 96.5 K to 95.3 K (-1.24 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 67.81 | 900 | 61,029 | 96,495 | 97.4 K to 96.5 K (-0.92 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 67.80 | 5,400 | 366,120 | 97,395 | 102.8 K to 97.4 K (-5.25 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Buy | M | 34.20 | 4,380 | 149,809 | 102,795 | 98.4 K to 102.8 K (+4.45 %) |
Apr 30 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Buy | M | 25.49 | 36,664 | 934,492 | 98,415 | 61.8 K to 98.4 K (+59.37 %) |
Feb 21 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Payment of Exercise | F | 61.91 | 1,002 | 62,034 | 61,751 | 62.8 K to 61.8 K (-1.60 %) |
Jan 04 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | A | 69.87 | 26,500 | 1,851,423 | 26,500 | |
Jan 04 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Payment of Exercise | F | 69.40 | 1,850 | 128,390 | 62,753 | 64.6 K to 62.8 K (-2.86 %) |
Jan 04 2008 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Grant | A | 0.00 | 8,500 | 0 | 64,603 | 56.1 K to 64.6 K (+15.15 %) |
Dec 21 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Gift | G | 0.00 | 150 | 0 | 150 | 0 to 150 |
Dec 21 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Gift | G | 0.00 | 300 | 0 | 56,103 | 56.4 K to 56.1 K (-0.53 %) |
Dec 21 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Gift | G | 0.00 | 150 | 0 | 56,403 | 56.6 K to 56.4 K (-0.27 %) |
Dec 21 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Gift | G | 0.00 | 150 | 0 | 56,553 | 56.7 K to 56.6 K (-0.26 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Payment of Exercise | F | 69.46 | 1,439 | 99,953 | 56,703 | 58.1 K to 56.7 K (-2.47 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Buy | M | 39.68 | 2,520 | 100,005 | 58,142 | 55.6 K to 58.1 K (+4.53 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Payment of Exercise | F | 69.46 | 1,439 | 99,953 | 55,622 | 57.1 K to 55.6 K (-2.52 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Buy | M | 42.98 | 2,326 | 99,970 | 57,061 | 54.7 K to 57.1 K (+4.25 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.77 | 100 | 6,977 | 54,735 | 54.8 K to 54.7 K (-0.18 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.76 | 315 | 21,974 | 54,835 | 55.2 K to 54.8 K (-0.57 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.75 | 400 | 27,900 | 55,150 | 55.6 K to 55.2 K (-0.72 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.74 | 500 | 34,870 | 55,550 | 56.1 K to 55.6 K (-0.89 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.58 | 500 | 34,790 | 56,050 | 56.6 K to 56.1 K (-0.88 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.57 | 100 | 6,957 | 56,550 | 56.7 K to 56.6 K (-0.18 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.56 | 600 | 41,736 | 56,650 | 57.3 K to 56.7 K (-1.05 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.55 | 300 | 20,865 | 57,250 | 57.6 K to 57.3 K (-0.52 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.54 | 1,700 | 118,218 | 57,550 | 59.3 K to 57.6 K (-2.87 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.53 | 1,100 | 76,483 | 59,250 | 60.4 K to 59.3 K (-1.82 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.52 | 800 | 55,616 | 60,350 | 61.2 K to 60.4 K (-1.31 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.51 | 300 | 20,853 | 61,150 | 61.5 K to 61.2 K (-0.49 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.50 | 500 | 34,750 | 61,450 | 62 K to 61.5 K (-0.81 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.49 | 200 | 13,898 | 61,950 | 62.2 K to 62 K (-0.32 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.48 | 300 | 20,844 | 62,150 | 62.5 K to 62.2 K (-0.48 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.47 | 200 | 13,894 | 62,450 | 62.7 K to 62.5 K (-0.32 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.46 | 500 | 34,730 | 62,650 | 63.2 K to 62.7 K (-0.79 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.45 | 1,100 | 76,395 | 63,150 | 64.3 K to 63.2 K (-1.71 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.44 | 200 | 13,888 | 64,250 | 64.5 K to 64.3 K (-0.31 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.43 | 300 | 20,829 | 64,450 | 64.8 K to 64.5 K (-0.46 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.42 | 300 | 20,826 | 64,750 | 65.1 K to 64.8 K (-0.46 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.41 | 500 | 34,705 | 65,050 | 65.6 K to 65.1 K (-0.76 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.40 | 1,600 | 111,040 | 65,550 | 67.2 K to 65.6 K (-2.38 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.39 | 500 | 34,695 | 67,150 | 67.7 K to 67.2 K (-0.74 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.38 | 900 | 62,442 | 67,650 | 68.6 K to 67.7 K (-1.31 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.37 | 500 | 34,685 | 68,550 | 69.1 K to 68.6 K (-0.72 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.36 | 300 | 20,808 | 69,050 | 69.4 K to 69.1 K (-0.43 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.35 | 1,500 | 104,025 | 69,350 | 70.9 K to 69.4 K (-2.12 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.34 | 400 | 27,736 | 70,850 | 71.3 K to 70.9 K (-0.56 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.33 | 600 | 41,598 | 71,250 | 71.9 K to 71.3 K (-0.84 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.32 | 700 | 48,524 | 71,850 | 72.6 K to 71.9 K (-0.96 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | M | 39.68 | 2,520 | 100,005 | 0 | |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | M | 42.98 | 2,326 | 99,970 | 0 | |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Option Exercise | M | 37.01 | 29,215 | 1,081,370 | 0 | |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.31 | 400 | 27,724 | 72,550 | 73 K to 72.6 K (-0.55 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.30 | 200 | 13,860 | 72,950 | 73.2 K to 73 K (-0.27 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.29 | 100 | 6,929 | 73,150 | 73.3 K to 73.2 K (-0.14 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.28 | 200 | 13,856 | 73,250 | 73.5 K to 73.3 K (-0.27 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.27 | 200 | 13,854 | 73,450 | 73.7 K to 73.5 K (-0.27 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.26 | 100 | 6,926 | 73,650 | 73.8 K to 73.7 K (-0.14 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.06 | 100 | 6,906 | 73,750 | 73.9 K to 73.8 K (-0.14 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.04 | 100 | 6,904 | 73,850 | 74 K to 73.9 K (-0.14 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.02 | 300 | 20,706 | 73,950 | 74.3 K to 74 K (-0.40 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.01 | 100 | 6,901 | 74,250 | 74.4 K to 74.3 K (-0.13 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 69.00 | 1,900 | 131,100 | 74,350 | 76.3 K to 74.4 K (-2.49 %) |
Nov 01 2007 | GR | GOODRICH CORP | LINNERT TERRENCE G | Executive VP & Gene ... | Sell | S | 68.99 | 800 | 55,192 | 76,250 | 77.1 K to 76.3 K (-1.04 %) |